On-demand webinar: Monitoring multiple products with one temperature data logger
Document
While cloud-based solutions have seen high implementation levels into specific portions of the supply chain in the pharma and life science industry, others have been neglected. Of course, one of the clear benefits of cloud-based temperature monitoring solutions for your data is cost-savings, but there are other tangible benefits for pharma companies that utilize cloud solutions to storage their temperature data.
Best practice for OTC monitoring which saves cost
What is on this page?
Click to jump to a specific section below.
Monitoring multiple products with one temperature data logger
Today, a supply chain without a cloud-based solution — of some kind — in place would be considered an outlier from the norm. According to Cisco Global Cloud Index, it was predicted that by 2021, cloud data centers would process 94% of all workloads.
During the webinar, we cover:
- Benefits with data in the cloud
- ERP integrations to ensure all data is captured
- Multi-product launches. Multiple products with one temperature data logger. Best practice for OTC monitoring which saves cost
- Powerful analytic tools with live status pulled from the cloud to make better decisions
Watch our webinar where we will take a closer look at the benefits of moving to cloud temperature management solutions to guarantee drugs are delivered safely to patients. Watch this webinar on-demand today by completing the form below.
You may also be interested in
Join Us at LogiPharma Europe 2026
From Temperature Data to Release Decisions—Rethinking Supply Chain Control
Read moreDownload Whitepaper
Change in the Management of TSS
We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.
Read moreDownload Whitepaper
Achieving FDA and EMA Compliance in Temperature Monitoring
Many pharmaceuticals and biological products require specific temperature conditions during manufacturing, storage, and transport to ensure their quality and safety. Failure to maintain these conditions can lead to product degradation, making them less effective or even dangerous.
Read moreDownload WhitepaperYou may also be interested in
What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
Extending TempMonitor BLE to Ultra-Low Temperatures
Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more